New study aims to help HIV patients in botswana kick the habit
NCT ID NCT05694637
First seen Jan 11, 2026 · Last updated Jun 23, 2026 · Updated 24 times
Summary
This study tests a program to help people living with HIV in Botswana stop smoking. It combines counseling with a medication called varenicline. The goal is to see if this approach helps them quit and improves their health. The study involves 750 participants who are daily smokers and on HIV treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Airstrip Clinic
Mahalapye, Central District, Botswana
-
Goodhope Primary Hospital
Good Hope, Botswana
-
Itekeng Clinic
Francistown, Central District, Botswana
-
Kanye Adventist Hospital
Kanye, Botswana
-
Kediretswe Clinic
Palapye, Botswana
-
Mahalapye District Hospital
Mahalapye, Central District, Botswana
-
Masego Clinic
Francistown, Central District, Botswana
-
Morwa Clinic
Mochudi, Central District, Botswana
-
Nyangabgwe Referral Hospital
Francistown, Central District, Botswana
-
Palpye Primary Hospital
Palapye, Central District, Botswana
-
Sefhare Primary Hospital
Sefhare, Central District, Botswana
-
Sekgoma District Hospital
Serowe, Botswana
-
Serowe Clinic
Serowe, Botswana
-
Thamaga Primary Hospital
Thamaga, Kweneng District, Botswana
-
Tutume Primary Hospital
Tutume, Central District, Botswana
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
varenicline
What this could lead to
If successful, this could provide an effective, scalable way to help people with HIV quit smoking, reducing HIV complications and deaths.
What could go wrong
This is a phase 4 trial, but results may not apply to all populations. Adherence to medication and counseling can be challenging, and the intervention may not work for everyone.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.